Open access
Jul 2026
RBM15 plays a key driving role in the tumorigenesis of EGFR-mutant lung adenocarcinoma and gefitinib resistance.
RBM15 promotes tumorigenic proliferation, suppresses apoptosis, and enhances gefitinib resistance in EGFR-mutant LUAD cells by regulating the EGFR signaling pathway and interacting with DGKE.
Mingsheng Ma, Wei Wang, Xiaoyan Wang et al.
· Scientific Reports · 0 citations